Nitric Oxide as a Potential Adjuvant Therapeutic for Neuroblastoma: Effects of NO on Murine N2a Cells

Neuroblastoma, the most common extracranial solid tumor in children, accounts for 15% of all pediatric cancer deaths. Pharmaceutical applications of S-Nitrosylation, which, under normal conditions is involved with a host of epigenetic and embryological development pathways, have exhibited great pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Jenna L., Reynolds, Melissa M., Brown, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355501/
https://www.ncbi.nlm.nih.gov/pubmed/32340209
http://dx.doi.org/10.3390/vetsci7020051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355501/
https://www.ncbi.nlm.nih.gov/pubmed/32340209
http://dx.doi.org/10.3390/vetsci7020051

Ejemplares similares